December 16, 2015
Hospice Providers: Submit Adjustments for Oral Anti-Cancer and Anti-emetic Drugs
The Centers for Medicare & Medicaid Services (CMS) issued the Medicare Learning Network (MLN) Matters® article, MM9255, "Reporting of Anti-Cancer and Anti-Emetic Drugs". This article explained that a Common Working File (CWF) edit restricted the hospice type of bill for certain anti-cancer and anti-emetic drugs. As a result, CMS instructed hospices to remove the drug codes from their claims to allow them to process until the error is corrected on January 4, 2016.
Beginning on/after January 4, 2016, hospice providers are encouraged to submit claim adjustments to add the unreported drug services in order to represent all their service costs in the claims data.
For additional information, please refer the MM9255 article at https://www.cms.gov/Outreach-and-Education/Medicare-Learning-Network-MLN/MLNMattersArticles/Downloads/MM9255.pdf on the CMS website.